Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make ...

The company's revenue jumped 77% in Q3 to reach $401.6 million in Q3 2024, alongside a net income of $75.6 million. It now ...

The expanded services help customers receive consultations and medications for erectile dysfunction, men’s hair loss, eyelash growth, motion sickness, and anti-aging skin care.

The bill states concerns over the prevalence of licensed health care professionals using their position to commit crimes ...

Amazon announced Prime members can access new upfront pricing for treatment of five common conditions such as erectile ...

Fintel reports that on November 14, 2024, B of A Securities downgraded their outlook for Hims & Hers Health (NYSE:HIMS) from ...

Citi analyst Daniel Grosslight has maintained their neutral stance on HIMS stock, giving a Hold rating on November 6. Daniel ...

Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.

Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.’s latest push into healthcare will ...

One Medical telehealth service is adding a new option that will put it in direct competition with digital health company ...

Amazon One Medical is expanding its telehealth services with the launch of upfront and low-cost treatment plans and ...